Active Surveillance of Papillary Thyroid Microcarcinoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Active Surveillance of Papillary Thyroid Microcarcinoma — Stella

Recruiting

Back to Papillary Thyroid Microcarcinoma trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Cedars-Sinai Medical Center, Los Angeles, California

Key details

Sponsor

Cedars-Sinai Medical Center

Enrollment target

~216 participants

Started

May 2016

Primary completion

December 2030

Age range

18 Years and older

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov